Mallinckrodt and Endo Announce $7 Billion Merger to Form Global Pharmaceutical Leader
Mallinckrodt and Endo announce a $7 billion merger. The merger aims for increased financial flexibility and synergies. Post-merger entity will be listed on the NYSE.
View signal analysis